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ABSTRACT 
The main objective of regenerative medicine is to replace or restore injured cells and tissues in the body. 
Stem cells are identified playing a key role in the regeneration but action of inflammatory mediators in 
disease is not well understood. In this work, stem cells from bone marrow, adult brain and spinal cord 
were studied with regards to regenerative possibilities.  
Paper I, Cell fusion has been observed during development and adult regeneration processes such as in 
heart, muscle and liver. Scientists have reported BMDC fusion with Purkinje neurons in cerebellum and 
that the BMDC nucleus can be reprogrammed to express Purkinje neuronal genes. Here we described 
in finding that, cell fusion between bone marrow derived cells and motor neurons in the spinal cord can 
take place. This is the first report demonstrating that motor neurons in spinal cord are able to fuse with 
hematopoietic cells during inflammation. We also identified the fusion phenomenon in spinal 
interneurons and in the olfactory bulb. In order to identify fusion event outside cerebellum, we used 
mice bone marrow transplantations and the EAE animal model. We identified fused motor neurons in 
the ventral horn expressing NeuN,and ChAT. Motor neuron identity was confirmed by tracing with 
axons in the sciatic nerve fibers to the cell body location in the spinal cord. We also observed that these 
fused neurons often are bi-nucleated. Yet, not all fused motor neurons were bi-nucleated, this might be 
due to technical difficulties or that other mechanisms might playing a role during fusion. 
Paper II, Is focused on how inflammation affects endogenous neural stem cells distant from EAE 
lesions in spinal cord. We isolated NSC from different levels of the EAE affected spinal cord and we 
report that inflammation during EAE can affect NSC that are distant from lesion site. NSC from normal 
appearing spinal cord showed increased proliferation, altered gene expression and differentiation profile 
in-vitro. We detected that, NSC in normal appearing spinal cord displayed increased neurogenesis and 
reduced oligodendrocyte differentiation after the inflammatory event. 
Paper III, We asked whether transplantation of NSC from subventricular zone improves hind limb 
function in spinal cord injured rats. For this, we isolated SVZ-NSC expressing eGFP and transplanted 
into immune compatible rats after SCI. We observed that transplanted NSC survived until 12weeks of 
post injury, filled the cyst and differentiated predominantly into oligodendrocytes (CC1), astrocytes 
(GFAP) and few neurons (ß-III tubulin). We observed that the animals received NSC improved hind 
limb function, decreased pro-inflammatory profile in cerebrospinal fluid and altered gene expression in 
the grafted cells. Further, ablation of the transplanted NSC using diphtheria receptor transfection, 
confirmed that, recovery of animal was due to the influence of the transplanted NSC. 
Conclusion: BMDC fuses with motor neuron and interneurons in entire neuroaxis and these events 
increases during inflammation. Inflammatory lesions can affect differentiation and proliferation of NSC 
that are present in the normal appearing spinal cord distant from the site of inflammation. Finally, 
transplantation of NSC after spinal cord injury improves hindlimb recovery in rats. 
 
Key words: neural stem cells, inflammation, cell fusion, regeneration, reprogramming, EAE, spinal cord injury, 
transplantations 	  
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1 INTRODUCTION 
1.1 REGENERATION IN CENTRAL NERVOUS SYSTEM 
During early 20th century Ramon Y Cajal who was a pioneer in the neuroscience field with his 
structural illustrations of the brain introduced the notion that adult brain neurons can’t be 
regenerated after termination of development. He also reported that the brain neurons have 
fixed connections that would disappear during aging 1-3. This neuron theory prevailed due to 
available resources 100 years back and dominated in the field of neuroscience for long time, 
and the concept became the foundation of modern neuroscience. However, this dogma was 
challenged by many studies that provided clear experimental evidence on the existence of adult 
neurogenesis. In the first contradictory experiment in 1963 Joseph Altman injected 3H-
thymidin in adult rats and cats intraperitonially and observed thymidine incorporation in the 
neurons4. Later experiments provided ample evidence on adult neurogenesis in birds5, rodents6 
and non-human primates7. In 1999 Alvarez-Buylla et al., showed that astrocytes that reside in 
the subventricular zone are the neural stem cells and generate new neurons in olfactory bulb8. 
In the same year, Johansson et.al., demonstrated the presence of ependymal stem cells in the 
spinal cord with neural stem cell properties and that they proliferate, migrate and contribute to 
scar in spinal cord injury9. Later Barnabe-Heider et al., showed in transgenic mice that, the 
presence of different population of stem cells in intact spinal cord and after spinal cord injury 
a large number of cells were generated from self-duplication of ependymal cells and 
astrocytes10. This was the first evidence with genetic fate mapping indicating that stem cells in 
intact spinal cord acts differently in injury than in normal homeostasis. Fagerlund et al., 
identified neural stem cells in brainstem, they demonstrated that during hypoglossal nerve 
avulsion injury, ependymal cells in brainstem proliferate, migrated but rarely differentiated into 
neurons11. All these experiments led to the conclusion that the adult mammalian brain 
neurogenesis takes place in two regions in normal homeostasis; the subventricular zone (SVZ) 
of lateral ventricles and subgranular zone of dentate gyrus in hippocampus12. While, upon 
injury, ependymal cells acts as stem cells in spinal cord13 and brainstem in rodents11. 
The first report in human hippocampal adult neurogenesis came from Eriksson et al. He 
identified BrdU positive neurons in human hippocampus from patients that had undergone 
BrdU treatment for cancer, indicating newly generated neuron in adult humans14. Later, these 
results were confirmed in different laboratories15. In another attempt to identify neurogenesis 
in humans, Spalding et.al., used C14 dating method to determine the timing of birth of individual 
cells thereby identify neurogenesis16. Using this method Frisen et.al., showed neurogenesis in 
human olfactory bulb, but it declined in adults as compared to children17; in human striatum18. 
Using the C14 approach Frisen et al., showed that human neurogenesis occurs after stroke, but 
these neurons were unable to integrate with the host tissue19. Later it was confirmed in animal 
models that astrocytes in striatum generate new neurons after stroke20. Now it’s been widely 
accepted that neurogenesis and regeneration can occur in the mammalian central nervous 
system (CNS). However, recently, two independent reports on adult human neurogenesis 
reignited the debate; Sorrells et.al., 2018 concludes that neurogenesis in adult human 
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hippocampal dentate gyrus is at undetectable level where as Boldrini et al., 2018 concludes the 
opposite i.e., lifelong neurogenesis in human hippocampus21,22. 
1.2 CNS REGENERATION ACROSS THE SPECIES  
Tissue regeneration and repair processes occurs in almost all organisms but when we observe 
closely in animal kingdom, the degree of regeneration vary greatly between species. In 
primitive animals like invertebrates to higher order mammals, wound healing process is 
conserved whereas regeneration potentials of CNS greatly diminished. This might be due to 
that the specific genes expressed in regenerative species were lost/silenced during evolution. 
Many evolutionary conserved genes have been identified across the animal kingdom, such as 
Caenorhabditis elegans genes (Dural lucine zipper Kinase-1 DLK-1 in axon regeneration are 
conserved in human23) in human development and disease. Therefore, understanding the 
genetic mechanisms across species might be useful in studies of CNS regeneration. I would 
like to discuss briefly about how regeneration event has been changed during millions of years 
of evolution from invertebrates to mammals. 
Invertebrates like planarian and Hydra regenerates not only CNS but the entire organism. The 
planaria ability to regrow the entire body depends on the presence of number of neoblasts. 
Neoblast is a specialized adult cell that is pluripotent and constitutes at about 25-30% of the 
cell population. These neoblast actively divides, migrates and accumulates as groups of cells 
at the vicinity of the injury called blastema. Neoblasts in Planaria are able to generate all the 
cells of the body and are pluripotent (can be compared with pluripotent embryonic stem cells 
in mammals). These neoblasts in blastema divide and differentiate into sub-populations called 
clonogenic neoblasts24. These clonogenic neoblasts are lineage-restricted (similar to 
multipotent adult stem cells in mammals), and these further differentiates into adult tissue and 
can regenerate the entire animal25. Recently, using single cells RNA sequencing technique, a 
sub-population of neoblasts called nb2 cells were identified and also transplantation of single 
pluripotent nb2 cell regenerated entire Planaria26 Unlike Planaria, the Hydra doesn’t have 
pluripotent stem cells but it has three different types of stem cells in its body (ectodermal stem 
cells, endodermal epithelial stem cells and intestinal stem cells) and these three types of stem 
cells together contribute total body regeneration27. Primitive vertebrates such as amphibians 
and fish have tremendous potential to regenerate almost the entire CNS, telencephalon, 
preoptic region of hypothalamus, midbrain, cerebellum and the spinal cord28-32 but fail to 
regenerate an entire body. Urodeles amphibians such as salamander is well studied in 
regeneration experiments and has a remarkable capacity to regenerate a wide range of tissues 
and organs after injury/amputation including limbs33,34, tails35, jaws33, heart, spinal cords35, mid 
brain36, retina and the eye37. Several mechanisms by which salamander limb regeneration can 
occur was identified including: the presence of lineage restricted progenitors38, 
dedifferentiation of Pax7 cells39,40 and activation of muscle satellite cells33,39. Zebrafish (teleost 
fish) can regrow heart, fins, retina, spinal cord upon amputation by different mechanisms.  
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Figure 1. Illustration representing how regeneration capacity compromised during evolution: 
Invertebrates have less complex CNS and immune system than in the mammals. At about 20-30% of 
body cells acts as pluripotent stem cells (Planaria) whereas in mammals limited multipotent stem cells 
identified in specialized niches (Modified and reproduced with permission from publishers Grandel et al 
201344, Popvich et al., 200845 Andong Z et al. 201646, Tanaka E et al 200947) 
These mechanisms identified in Zebrafish robust regeneration are; lineage-restricted 
progenitors, which migrate into amputation plane and forms blastema in similar way as in 
salamanders41,42, dedifferentiation of osteoblast that forms bone and activation of stem cells, 
which regenerate muscle tissue43. Neurogenesis in birds was first discovered in songbirds5 in 
which during the spring male birds produce songs to attract female birds whereas in fall they 
were not singing. The telencephalic song controlling nuclei in the brain of adult male birds is 
70-99% larger in spring than in fall due to the learning of new songs. Later pulse-chase 
experiments using 3H-thymidine confirmed that, new neurons were generated from the 
precursors cells that were present in the ventricular zone of the forebrain48-50. 
Regeneration of retina in zebra fish is well studied, in which specialized glial cells called Muller 
glia (MG) proliferate and dedifferentiates into retinal cells51. However, in mammals such as 
mice, MG lack the regenerating capacity but upon injury, they proliferate and differentiate into 
limited number of neurons52,53. Recently, Yao et al, reported that, following gene transfer of β-
catenine into mutant mice with congenital blindness restored their vision via MG proliferation 
and differentiation54. This indicates that certain genes involved in regeneration were 
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lost/silenced during evolution and they can be activated. In mammals the regeneration capacity 
is very limited to certain organs such as skin55, blood vessels, gut, fingers56, eye and liver. 
Moreover, the capacity to regenerate the tissues further decreases with age. Even in some 
organs it appears that, the regenerative capacity will remain for very brief period of time and 
later it disappears, for an instance, mice heart have great regenerative capacity after partial 
surgical resection but it is lost after 7days of birth57. During finger digit regeneration of mice 
and juvenile human58 appearance of fate restricted progenitors59 has been reported only for brief 
period of time. CNS has poor regeneration and do not spontaneously regenerate its axon after 
injury (further discussed in SCI section, for more information on evolutionary regeneration 
read the reviews Grandel 201344; Popvich, 200845; Andong Z, 201646; Tanaka E, 200947). 
Although, mammals have lost their dedifferentiation capacity in different tissues during 
evolution process Schwann cells can undergo dedifferentiation during peripheral nervous 
system regeneration. Dedifferentiation of Schwann cells was reported to be age dependent and 
its dedifferentiation capacity declined as the cells gets older60,61. 
1.3 REGENERATION OF PERIPHERAL NERVOUS SYSTEM AND CNS 
The peripheral nervous system (PNS) is the component in the nervous system that contains all 
the nerves and ganglia that residing outside of CNS, however, the cell body may be located 
inside the CNS as for motor neurons. PNS main function is to connect CNS (brain and spinal 
cord) to the limbs and organs. The neurons in the PNS has maintained robust regenerative 
ability which often results in at least partial recovery of function after PNS damage whereas in 
this CNS has been questioned. 
Upon PNS injury the distal part (i.e. farther from the neuron’s cell body) of the nerve that is 
disconnected with cell body undergoes degeneration called Wallerian degeneration. The 
proximal part of the axons that are in contact with cell body may re-innervate their targets and 
complete regeneration can occur62. PNS contains specialized Schwann cells that myelinate 
axons, regulates ion and metabolite concentration and enrich regeneration of axons. In the CNS 
oligodendroglia produce myelin and astrocytes have many functions but importantly regulate 
ionic concentration. Schwann cells are divided into two types based on their function 
myelinating and non-myelinating Schwann cells. This myelination capacity of Schwann cells 
depends on the axons on which Schwann cells are in first contact with. Both Schwann cells and 
oligodendroglia produce and maintain myelin around axon that provides high-resistance and 
speed in axonal action potential of neuron. One of the reasons for the difference in regeneration 
between CNS and PNS is due to non-permissive environment generated by oligodendroglia 
and astrocytes in CNS whereas Schwann cells have stimulatory effect on axonal elongation in 
PNS. Following axotomy in PNS, the mononuclear cells from peripheral blood secretes 
cytokines such as interleukin-1(IL-1) and platelet-derived growth factor (PDGF), which 
stimulate Schwann cell proliferation and down regulates its myelin components. These 
activated Schwann cells forms cell aggregates near to axon and provide growth factors such as 
brain derived neurotrophic factor (BDNF)63 ciliary neurotrophic factor (CNTF)64 fibroblast 
growth factor (FGF)65 and nerve growth factor(NGF)63,66,67. These growth factor promote 
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neurite outgrowth by stabilizing cytoskeleton of axons. Whereas in CNS injury, 
oligodendroglia upregulate myelin associated inhibitors (MAI), such as Nogo-A68,69, myelin-
associated glycoprotein (MAG)70, oligodendrocyte myelin glycoprotein (OMgm)71, and 
astrocytes secretes chondroitin sulfate proteoglycans(CSPG) that contain inhibitory molecules 
for axon regeneration (for detailed review on MAI see 72,73). Pioneering work by Aguayo and 
his colleagues demonstrated that, when sciatic nerve grafts were transplanted into a CNS lesion, 
neurons can regenerate axons for a long distance across a lesion by means of peripheral nerve 
bridge74-77. During PNS injury neurons could upregulate regeneration associated genes (RAG’s) 
such as c-Jun78, activating transcription factor-3 (ATF-3)79, SRY-box containing gene 
11(Sox11)80, growth-associated protein-43 (GAP-43)81 where in CNS these genes were 
upregulated at modest levels compared to PNS. Over all, not only the extrinsic molecules 
secreted by Schwann cells, oligodendroglia and astrocytes makes the difference between PNS-
-CNS regeneration capacity but also neuronal intrinsic factors contribute to the poor 
regeneration in CNS62. 
1.4 CELL FUSION 
1.4.1 Cell fusion and regeneration  
Life starts with fusion between oocyte and sperm, which forms zygote and eventually the 
zygote generates a new organism. Cell fusion is not only involved in life formation but this 
biological phenomenon can be observed from zygote to adult animal in normal growth and 
development also during in tissue repair or regeneration process. Caenorhadditis elegans well 
studied in the cell fusion process in which one third of the somatic cells undergoes fusion during 
its normal development82. During development stage, larvae seam cells fusion results in 
reprogramming of the larval cells, which differentiate into adult terminal cells. This fusion 
process depended on AFF-1 (Anchor cell Fusion Failure -1) protein expression83. Cell fusion 
occurs not only in worms but also observed in across species, like in Drosophila melanogaster 
(Fruit fly), Danio rerio (zebra fish), birds, rodents and in mammals including humans. In 
humans, the fusion process observed in different developmental stages such as human 
trophoblasts fusing to form multinucleated syncytiotrophoblasts that enables implantation of 
embryo and the supply of nutrients between mother and fetus. Also, a series of events after 
fusion between mononucleated myoblasts progenitors leads to formation of multinucleated 
myotubes during muscle formation and repair84 and macrophages fuse together and form 
multinucleated giant cells(MGC’s) called osteoclasts during normal development and these 
osteoclasts maintain, repair functions and can remodel bone85,86. Upon fusion, bone marrow 
derived stem cells (BMDC) were reprogrammed to switch their hematopoietic lineage and 
attrain properties of other non-hematopoietic tissues during regeneration. This phenomenon 
was observed in wide range of tissues in rodents and human like neurons, hepatocytes in liver, 
myocytes in muscle and other tissues87. It’s been hypothesized that somatic cells 
reprogramming after bone marrow derived stem cells fusion leads to the retainment of stem 
cell plasticity in different tissues88. 
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1.4.2 Cell fusion and reprogramming  
In late 80’s, identification of cell-cell fusion process in different tissues during development 
and regeneration encouraged many scientists to find out the exact mechanism of cell fusion and 
this led to the development of in-vitro models to understand stem cell plasticity. 
Reprogramming of cells and differentiation by cell-cell fusion in-vitro were first reported using 
ES cells, where the bone marrow cells adopted properties of other cells after spontaneous fusion 
with ES cell89,90. These in-vitro studies paved a path to mechanisms by which adult cells change 
their fixed identities, that was considered impossible few years ago, and were named as 
reprogramming of cells. To date the mechanism of somatic cell reprogramming is well 
established, this can be done three different ways; somatic cell nuclear transfer (SCNT), cell 
fusion and direct reprogramming all depicted in figure 2 below.  
 
Figure 2. Nuclear reprogramming using different methods: 
(Modified and reproduced with permission from springer nature; Yamanaka 2010; Dittmar, 201191,92) 
The SCNT method aim is to generate pluripotent cells in which nucleus is transferred from 
somatic cells into an enucleated oocyte (Figure 2). This method is similar to early cloning 
experiment performed by Briggs and King 1952 where they generated cloned frog eggs93, later 
it’s been shown in sheep (Dolly) and confirmed that somatic cells can be reprogrammed to 
totipotent cells94. The major problem in SCNT is the efficiency (about 2-3%) and the survival 
of the clones. Early experiments in 1978 (where embryonic stem cell (ESC) cultures had not 
been established) embryonic carcinoma cells (ECC) were used in reprogramming somatic cells 
to attain pluripotency through cell fusion. Fusion experiments with ECC/ ESC and 
neurospheres (NSC) revealed that not only the gene expression in NSC was changed but also 
changed DNA, methylation, which caused NSC to lose their epigenetic memory95. This 
concluded that fusion induced hybrid cell will lose their somatic cell properties and attains 
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pluripotency and subsequent experiments identified Oct4, KLF as key components in 
reprogramming96,97. In 2006 Yamanaka et al., showed that somatic cells like fibroblast can be 
reprogrammed to ESC like state using Oct4, Sox2, Klf4 and C-Myc transcription factors and 
the cells were called induced pluripotent stem cells (iPS) (Yamanaka awarded with Nobel prize 
in 2012 along with John Gurdon who reprogrammed cells using frog eggs by fusion)98 
1.4.3 Cell fusion in the CNS 
Multipotent adult stem cells are defined as an immature cell that have the ability to self-renew 
and differentiate into mature cells in the organ they reside. The extent of regeneration of stem 
cells depend on their plasticity, which depends on their developmental germ layer origin. 
During late 1990’s studies on stem cell populations using bone marrow chimeric mice ignited 
interest into plasticity, where bone marrow cells were labelled with LacZ or GFP that enabled 
their detection in non-hematopoietic cells. Upon fusion some cells expressed neuronal specific 
antigens like NeuN, neurofilament, and ßIII tubulin indicating that bone BMDC entered into 
brain and cerebellum and transdifferentiated in neurons99,100. Transdifferentiation of BMDC in 
CNS was quickly questioned, later two independent groups observed spontaneous fusion 
between BMDC and embryonic stem cells in-vitro leading to transfer of its genetic material 
and mixing their cytoplasm which resulted in heterokaryon formation89,90. This in-vitro 
experiments encouraged to evaluate this mechanism further in-vivo. In 2001 Nakono et al., 
transferred BMDC from male donor to female recipients so that BMDC could be identified not 
only with expression of GFP but also using identification of the male Y chromosome in the 
cells of female recipients in transgenic rodents. In these studies, bone marrow depletion was 
achieved either using lethal irradiation or by using the PU.1 null mouse model. PU.1 is a 
member of the ETS family of transcription factors expressed exclusively in cells of 
hematopoietic lineage. The PU.1 homozygous mutant mouse is born alive but die from severe 
septicemia within 2 days after birth but it can be treated with bone marrow transplant within 
2days101-103.  
Human studies on post-mortem brain, from individuals who had received bone marrow 
transplantation due to hematological malignancies showed BMDC contributed to neuronal 
cells in neocortex and hippocampus104 and a subsequent study confirmed that the fusion process 
takes place 1-2% neurons in hippocampus105. In 2003 Weimann et al., studied biopsies from a 
female who had received bone marrow from male donor and found that bone marrow derived 
stem cells contribute heterokaryon formation in Purkinje neurons of cerebellum. Since a sex-
mismatched bone marrow was transplanted, using fluorescent in situ hybridization (FISH) 
technique detected tetraploid (XXXY) Purkinje neurons were detected. This led to 
confirmation of cell fusion between BMDC and Purkinje neurons in cerebellum. Subsequent 
animal studies from the same lab addressed fusion process in animal models by transferring 
GFP positive bone marrow donor to sex-mismatched recipients. These experiments showed Y 
chromosome in Purkinje neurons, further confocal images showed bi-nucleated cells indicating 
cell fusion. This is first clear report that provided a substantial evidence for BMDC contribution 
through cell fusion rather than trans-differentiation. More over the bone marrow transplantation 
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between rat and mouse model demonstrated that, Purkinje neurons lacked expression of 
hematopoietic markers (CD11b, F4/80 and CD45) and that the fused BMDC nucleus was 
reprogrammed to express Purkinje neuron specific genes106. Parabiosis experiment (a surgical 
union of rodents to share the blood circulation) confirmed that cell fusion between BMDC and 
Purkinje neurons is not due to the radiation caused by irradiation106,107. In 2003 using Cre/lox 
recombination Alvarez-Dolado confirmed the fusion between BMDC and Purkinje neurons in 
cerebellum108,109. The in-vivo mechanism of cell fusion is not fully understood, in-vitro over 
expression of Nanog in mouse ESC and Sall4 in mouse embryonic fibroblast resulted an 
increase in cellular fusion and reprogramming110,111. 
Too little is known about the cell fusion mechanism of regulation and its biological 
significance. Johansson et al. in 2008 demonstrated that the cell fusion phenomenon increased 
10-100 folds during chronic inflammation such as idiopathic ulcerative dermatitis and 
experimental autoimmune encephalomyelitis (EAE)109. Hematopoietic stem cells (SP, Lin-, 
Sca1+, c-kit+) could fuse with Purkinje neurons and the cell started to express Purkinje cell-
specific genes (Calb 1, Pcp 2, Kcnc 1, Gsbs) but not hematopoietic antigens (CD45, CD11b, 
F4/80 and Iba1). This experiment elegantly demonstrated that, the BMDC nucleus is 
reprogrammed into Purkinje neuronal fate/function. These bi-nucleated Purkinje neurons were 
observed over long period (36-56 weeks after bone marrow transplant) which further concluded 
that, fusion process and heterokaryon formation are not a transient but stable processes109. 
1.5 STEM CELLS  
Stem cells generates identical copies of themselves (self-renewal) and also give rise to daughter 
cells that have lineage-specific differentiation potentials. This mechanism of cell division 
where two sister cells have different fate are called asymmetric division (Figure 3). 
  
Figure 3. Illustration showing how NSC maintaining its stemness. 
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Several types of stem cells have been identified based on their origin and plasticity (the 
differentiation capacity): embryonic stem cells (ES) isolated from inner cell mass of the 
blastocyst, recently, reprogrammed cells called induced pluripotent stem cells (iPS cells)98 that 
acts like ES cells, and adult stem cells from different tissues. Pluripotent ES cells are able to 
generate almost all the types of the cells in the body. Whereas, adult stem cells are differentiated 
and more committed or limited toward specific lineage are named multipotent. In 1981 two 
independent labs (Evans and Kaufman; Martin ) derived ES cells from mice112,113 and 
established in-vitro protocols for ES cells propagation, later the protocols were improved and 
established ES cell lines in rat 114,115 as well as in human116. (For ES cell historical development 
review see review Jun Wu, 2016117). However, the expression of pluripotency marker in 
multipotent tissues questioned the definitive term for potency118. 
1.5.1 Adult stem cells  
Adult somatic stem cells or adult stem cells are rare populations of cells present in various 
organs and believed to be involved in maintaining tissue regeneration. These cells are 
multipotent, capable of self-renewal and generate progeny that differentiate into a limited 
number of adult cell types. Adult stem cells are usually in a quiescent state. External stimuli, 
such as injury, activates their proliferation and differentiation to replace the damaged tissue. 
There are many kinds of adult stem cells. Here, I would like to focus on adult neural stem 
cells119. 
Adult neurogenesis is extensively studied and it’s now well established that neural stem cells 
reside in the adult mammalian brain in specialized niches and they contribute to tissue 
homeostasis120. Two regions were identified with large population of NSC in mammalian brain; 
1. the subventricular zone (SVZ) located in the linings of lateral ventricles 2. subgranular zone 
(SGZ) in the dentate gyrus of hippocampus121. In both niches new neurons are generated and 
they are integrating into pre-existing neuronal circuits. NSC in the SVZ divide and generates 
neuroblasts that migrate rostrally into olfactory bulb where they become interneurons122. 
 
 
Figure 4. Illustration showing NSC migration in SVZ into olfactory bulb: 
(Adopted with permission from CSHL press, Daniel et al., 2016)  
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NSC niche in SVZ has extraordinary micro-environment that facilitates cell- cell interactions 
and soluble factors interaction. The ependyma of lateral wall of brain composed of multiciliate 
cells called ependymal cells and these cells are in close contact with cerebrospinal fluid123. 
However electronic microscopic studies revealed that not only ependymal cells but type 
B1cells with single primary cilium were also in direct contact with CSF. These type B1 cells 
aggregates at the center of ependymal cell in a “pinwheel” pattern and extend a long process 
that in contact with blood vessel. These B1 cells are identified as astrocytes8 in the brain 
expressing glial markers GFAP, GLAST and BLBP123,124. These B1 cells may exits the 
quiescent state, undergoes self-renewal by asymmetric division125-128 and then gives rise to 
transit-amplifying cell or type C cell123,129,130. Recently, Obernier et al., combined short term 
and long-term tracing experiments with retro viral injections in SVZ showed that quiescent B1 
cells generates type C cells by symmetrical division131. 
Type C cells further generates neuroblast or type A cells and expresses transcription factor 
Ascl1 or Mash1 and Dlx2123. These neuroblast expresses marker PSA-NCAM and doublecortin 
(DCX) and migrates in rostral migratory stream (RMS) and upon reaching olfactory bulb 
neuroblasts differentiates into interneurons132 in rodents (Figure 4). Although the mechanism 
by which type B1 cells are maintaining the stem cell niche is well studies the precise surface 
antigens have not yet identified. Activated NSC express epidermal growth factor receptor 
(EGFR)133 and recently VCAM1 expression was observed in the apical process of NSC134. 
These NSC can be readily propagated as neurospheres in presence of mitogens such as 
epidermal growth factor (EGF) and fibroblast growth factor (FGF).  
1.6 STEM CELL TRANSPLANTATIONS 
As discussed previously, CNS has poor regeneration and fewer number of stem cells in higher 
animals (Figure-1) and development of protocols that expand stem cells without affecting their 
potency in-vitro encouraged many scientists to transplant stem cells in different disease models 
aiming to replace cells that were lost due to injury or degeneration. There were numerous 
attempts made using different types of stem cell in animal models as well as in human135. Stem 
cells were transplanted in neurodegenerative disease like amyotrophic lateral sclerosis 
(ALS)136, Parkinson’s disease (PD)137,138, Alzheimer’s disease (AD)139 and Huntington’s 
disease140 and in injuries SCI, TBI, and stroke. Indeed, studies in rodent Parkinson’s model 
have showed transplantation of dopaminergic neurons elicit functional recovery141. However, 
in human clinical trials with 800 patients observed mixed results due to many reasons142. In 
animal model of SCI different types of stem cells were transplanted, such as mesenchymal stem 
cells, embryonic stem cell derived NSC, adult tissue derived NSC, human fetal stem cells, 
induced pluripotent stem cell derived NSC. All these studies concluded that, modest to 
significant recovery could be achieved in animal models. The main beneficial mechanisms 
proposed are mesenchymal stem cells secretion of trophic factors (NGF, BDNF, GDNF, 
CNTF, EGF, VEGF-A); NSC enhance axonal regrowth and promote remyelination143,144; 
differentiation of NSC into astrocytes oligodendrocytes and neurons145-148; NSC transplanted 
acute and subacute also secreted neurotrophic factors and could differentiate149; and also 
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reduced inflammation150-152. In 2012 Lu et al., demonstrated that transplanted human fetal spinal 
cord derived neural stem cells in growth factor matrix could extends axons across the injury147, 
these results were re-assessed and confirmed153. This was the first evidence showing that 
transplanted NSC can extend their axons across the injury for about 3cm distance in rat SCI 
model. Similar results were obtained using human iPS cell derived NSC in rat SCI model154. 
The first phase I study using NSC in chronic spinal cord injury was initiated155. 
1.7 REGENERATION OF CNS AFTER INJURY 
Our body generates new cells continuously during the process of replacing the cells that were 
lost due to age, DNA damage, or other processes. The similar mechanisms are engaged during 
replacement of cells that were lost due to injury. However, in mammals, the CNS has, in 
comparison to other species, minimal regenerative capacity and fails to subsequently to injuries 
such as spinal cord injury (SCI) and traumatic brain injury (TBI). Traumatic CNS injuries (SCI 
and TBI) are the one of the leading causes of death and severe disabilities are seen in the entire 
world156-159. In lower vertebrates such as Zebrafish, the spinal cord regenerates after transection 
injury42. The cause for the low regeneration in mammals might depends on the complexity of 
the mammalian CNS, a complex and advanced immune system and lack of sufficient number 
of adult stem cells. In mammals the inflammatory response to CNS injury leads to several 
cascades of events which eventually inhibits the regeneration (Figure. 1). The regenerative 
response to injury depends on severity of the injury, damaged area and degree of inflammatory 
response160. The initial phase of immune response to the injury has a beneficial role to clear 
dead cells but later this response itself may cause irreversible secondary damage160,161 
(mechanism of inflammation is discussed more detail in spinal cord injury section).  
1.8 SPINAL CORD INJURY 
Spinal cord injury (SCI) is often a sudden devastating event occurring majorly by accidents 
and often results in permanent loss of motor, sensory and autonomic functions from below the 
site of injury in complete spinal cord injuries156,162 . The global occurrence of traumatic spinal 
cord injury is about 750 incidents per million affecting more younger people (global average 
age 38 years) affecting morbidity and quality of life162.  
1.8.1 Pathophysiology of spinal cord injury 
The pathophysiology of SCI can be defined into two phases, the primary injury and the 
secondary injury. The primary injury is due to initial disruption of spinal cord due to 
mechanical force/trauma and results in loss of neurons and demyelination. Following, the 
primary phase a series of events such as loss of neurons, demyelination, inflammation, free 
radical production, excitotoxicity, glial scar and cyst formation which leads to further 
destruction of spinal cord leading to permanent damage. To better understand the SCI, the 
injury events are categorized into immediate, acute, intermediate and chronic state of SCI163. 
Within minutes up to two hours after injury, axonal disruption, necrotic death of neurons and 
glial cells, edema, vascular disruption and hemorrhage, ischemic reaction in many segments 
from the injury, and a subsequent spinal shock; all these events cause instant functional loss at 
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and below the site of the injury. Even though the spinal cord anatomically grossly may appears 
normal intact after injury the integrity of the CNS may be seriously disrupted with massive 
activation of microglia and increased level of pro-inflammatory cytokines have been 
reported164. 
During acute the phase, when the secondary injury begins (2hr to 2weeks) with further vascular 
disruption may lead to hemorrhage and ischemia causes loss of normal autoregulatory 
mechanisms and increased necrosis of neurons. Neuronal loss and cellular injury results 
dysregulation of intracellular Ca2+ concentration, DNA damage causes apoptotic death165 of 
neurons and large number of astrocyte and oligodendrocytes166. Elevated levels of reactive 
oxygen species (ROS) are observed until 2 weeks after injury, this causes oxidation of lipids 
and further cellular loss and irregular intracellular Ca2+ ion concentration which in turn may 
cause a negative cyclic loop of neuronal loss in spinal cord. During the acute phase disruption 
of blood brain barrier (BBB) causes infiltration of immune cells (T cells, neutrophils and 
monocytes) into CNS which contributes to an inflammatory response167. These series of events 
activate astrocytes to become reactive, in which GFAP is increased significantly and the 
reactive astrocytes form a gliotic scar. Stem cells from the ependymal region divide and 
differentiates into astrocytes13 and start to form scar tissue. Recently, Frisen’s lab showed that 
pericytes from blood vessels proliferates and outnumber astrocytes in scar formation in Glast-
CreERxR26R-YFP mice168. Reactive astrocytes not only form a scar in SCI but also decreases 
edema, helps in maintaining ionic homeostasis and permeability of BBB and decreases 
infiltration of immune cells169. During the intermediate phase from 2 weeks to 6months of SCI, 
where astrocytes and pericytes contribute to the glial scar formation and its maturation. From 
3 weeks post injury regenerative events appear, such as axonal sprouting in corticospinal tracks, 
but these events are not enough to recover from SCI170. The chronic injury phase persists the 
entire lifetime from 6 months of injury171,172. The glial scar continues to form and injured axons 
undergo Wallerian degeneration. Due to massive cell death and secondary inflammation, a 
cavity filled with CSF called cyst often appears at lesion site. Until to date, there are no cures 
for SCI, routine treatments for SCI focuses on rehabilitation to improve functional outcome 
and coping with the consequences of the injury. Stem cell transplantation, epidural stimulation 
and other methods have demonstrated some recovery in animal models but these needed to be 
proved in human clinical trials173,174. 
1.8.2 Animal models of spinal cord injury 
Different animal species were used to study SCI (pigs, cats, dogs, non-human primates, 
invertebrates, rabbit, rat and mice) of which 70% of the studies were performed in rats175. It has 
been reported that thoracic spinal cord injuries were mostly commonly studied in animal 
models and it was observed that contusion and compression type of injuries better mimics 
human SCI pathology175. I would like to focus on historical prospect of how SCI animal models 
were generated over time.  
Several animal SCI models were developed to the understand the basic mechanisms of injury 
and to evaluate different treatment methodologies, of which contusion, laceration, chemical 
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mediated SCI were widely used. The laceration injury model is a complete or partial incision 
was made on the spinal cord (complete transection, incision, and hemisecting models are 
among them). These models are used to study the mechanism of regeneration or inhibition of 
regeneration across the lacerated area75,76. Contusion based models are popular due to their 
similarities to the clinical symptoms and histology of SCI. Allen in 1911introduced the weight 
drop model of SCI in dogs176. Later these models were improved and where the spinal cord was 
exposed after laminectomy under anesthesia and a known weight was dropped through a 
vertical tube on the spinal cord177. Later, the weight drop method reproducibility was questioned 
due to the bouncing effect and other practical limitations. Initial experiments of SCI were 
performed on dogs and cats using weight drop method. The clip compression injuries were 
developed in rats since rodents spinal cords were considered to be too small for the weight drop 
method. During compression injuries, the spinal cord is compressed rapidly with known force 
and predetermined time using forceps or clips178. More laboratories became interested in 
generating animal models of SCI that allowed more control over the injury and its biochemical 
properties matched with human SCI. However, due to lack of commercial availability of 
standardized SCI instruments, the reproducibility of SCI greatly challenged. Recently, 
contusion-based instruments were developed (OSU device, MASCIS) and also made available 
commercially (IH impactor)109 where SCI generated with predetermined force using a 
computer179,180. We used IH impactor in our experiment, where force was used to deliver impact 
on the spinal cord. IH impactor principle is same as the weight drop method but it avoids 
bouncing effect and using controlled force allow researcher to reproduce the similar impacts 
on the spinal cord. After the SCI, the probe connected to the impactor detects displacement of 
the tissue, which allow researchers to pre-eliminate the animals that were not successfully 
injured. 
1.9 MULTIPLE SCLEROSIS 
Multiple sclerosis (MS) is a chronic, neuroinflammatory, demyelinating progressive disorder 
in CNS affecting 2.3 million people globally181. In 1868 the French neurologist Jean Martin 
Charcot documented inflammatory lesions in brain and spinal cord of patients with 
intermittent neurological problems182. MS is more common in females than males (3:1) and 
onset is mostly between 20-40 years of age. Eighty percent of the patients experience 
recurring neurological problems that are partially recovered but often worsened over time. 
There are three types of MS types based on symptoms and disease progression: relapsing-
remitting MS (RR-MS, most common form of the disease where symptoms disappear for a 
period), Primary progressive MS (PP-MS,10% of the MS patients experience a continuous 
worsening of their symptoms) and secondary progressive MS (SP-MS, which evolves from 
RR-MS after certain period a time the disease). A complex interaction between the immune 
system, astrocytes, microglia, oligodendrocytes and their precursors and neurons result in 
oligodendrocyte death, axonal demyelination and axonal loss183. The disease is mediated 
through an autoimmune T cell reaction. However, the basic cause of MS pathogenesis is not 
fully understood. The animal models and human blood and CSF analysis confirms the 
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adaptive immunity (T cells and B cells)184 and mechanisms of innate immunity 
(macrophages)185 have major roles in MS. Clinical trials with drugs that limit T-cell entry 
into CNS ameliorated MS symptoms such as mitoxantrone, Fingolimod and B-cell depleting 
antibodies halt MS lesion formation and clinical signs of the disease (Rituximab or Rituxan). 
MS is a complex disease not only governed by genetic factors but also with extrinsic factors 
such as, environment, life style , Epstein-Barr virus(EBV) infection, low vitamin D, and 
smoking determine the vulnerability to MS186. Recently, it been shown that immunological 
mechanisms in the lung187 and bacteria in the gut188,189 may contribute to the pathogenesis of 
MS disease, however, these reports needed further validation. 
1.9.1 Experimental Autoimmune Encephalomyelitis 
The major pathological features of MS are inflammation and demyelination. Three 
principally different animal models have been used to study MS, experimental autoimmune 
encephalomyelitis (EAE), virus induced chronic demyelination (Theiler’s virus) and toxin 
induced demyelination models (cuprizone and lyso-lecithine)190,191  
In more than 100 years EAE is one of the most intensively studied animal models to 
understand immunology of MS. Historically, 1885 Louis Pasteur observed sporadic cases of 
paralysis after injecting dried spinal cord from rabbits that were pre-infected with rabies 
virus. In 1930 Rivers et al. performed a series of experiments in rhesus monkeys in order to 
investigate virus from inoculum caused the paralysis Pasteur cases. He included as a control 
group injected uninfected rabbit brain emulsion. Surprisingly two animals developed 
weakness in the hind limbs. Subsequent experiment clearly established the relapsing and 
remitting type of neurological disease after immunization192 and also showed that 
perivascular infiltrated cells destructing myelin is the cause for the symptoms. In 1947 Wolf 
et al., documented resemblance of EAE symptoms with human demyelinating disease193. In 
later experiments purified myelin proteins and adjuvant were used in the emulsion used for 
immunization. 	  
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2 MATERIALS AND METHODS 
 
Even though, the methods described in the constituent papers, I would like to write the methods 
section in detail because in scientific articles there is restriction of number of words to use. This 
makes some time hard to reproduce similar method in different labs. I am writing methods 
thoroughly so that reader can easily access the procedures if they would like to perform them. 
In paper I due to technical difficulties in irradiation and ethical consideration of parabiosis 
experiment, animal experiments such as bone marrow transplantation and EAE (section 2.3-
2.4) were performed at Stanford University School of Medicine, USA. All the animal 
experiments were approved by Stockholm ethical committee (Stockholm, Sweden) and the 
Administrative Panel on Laboratory Animal Care (APLAC, Stanford University School of 
Medicine and the IACUC) USA. 
2.1 ANIMAL BREEDING AND GENOTYPING 
Paper II and III: Lewis rats were inbred for at least 40 generation were using in the study and 
C57J mice were ordered from Jaxâmice. Animals were kept at room temperature (21 ± 1 °C) 
with 12:12h light and dark cycle and food and water ad libitum. Rats were obtained from Rat 
Research Resource Centre (RRRC, Columbia) and these LEW-Tg(EGFP)455Rrrcc transgenic 
rat expresses enhanced green fluorescent protein (eGFP) under ubiquitin C promoter on 
chromosome 5. Genotyping was performed using the protocol from RRRC to identity the GFP+ 
and wildtype (GFP negative) animals. Briefly the DNA from extracted from the ear biopsy of 
the littermates using RED Extract-N-AMP tissue PCR kit (Sigma). After PCR and 
electrophoresis animals that are carrying eGFP homozygous and heterozygous were selected 
as donors and eGFP non-carrier siblings wild type animals were selected as the receivers 
2.2 CELL CULTURE 
Paper II and III: Primary neural cells (NSC) were isolated from subventricular zone (SVZ) of 
adult Lewis rats that were expressing eGFP according to modified protocol from Johannsson 
et al., Briefly, Animals were euthanized using 20%CO2 and decapitated, carefully cerebrum 
isolated from the animal kept in +4℃, PBS. In paper II the spinal cord stem cells isolated 
(described in section 2.9), after dissociation of isolated spinal cord into single cells using 
papain, the Myelin and other debris were removed by density gradient centrifugation with 
30%percoll in 1xDPBS (Sigma, P1644). The supernatant discarded along with white myelin 
and carefully the pellet was resuspended in NSC growth medium. In paper III SVZ carefully 
isolated under surgical microscope and dissociated into single cells suspension using papain 
(Worthington, LS003126). The cells were washed in L15 medium (Life technology, 31415086) 
and cultured in Dulbecco’s modified Eagle’s medium DMEM/F12 medium (GIBCO 31331-
093) supplemented with B27 without RA (GIBCO 17504044), penicillin-Streptomycin 
100U/ml (Sigma, 15140122), 20 ng/ml of epidermal growth factor (EGF, Sigma E4127), and 
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10ng/ml of Basic fibroblast growth factor (bFGF, R&D Systems). Growth factors were added 
every second day and neurospheres are passaged after 4-5 days of plating.  
Differentiation of NSC: NSC were grown as neurospheres, dissociated into single cells using 
papain then washed with L15 medium and plated on the coverslips that were coated Poly-D-
Lysine. At around 10000 cells were plated per well in 24 plate and the differentiating medium 
containing 1% fetal bovine serum devoid of growth factors. For neurospheres differentiation 
assay same protocol followed using attached spheres after second passage. In paper II the 
concentration of nitrite in supernatants of NSC cultures was measured by Griess reaction using 
Griess Reagent (Sigma-Aldrich). 
2.3 BONE MARROW TRANSPLANTATION 
In paper I: 10-12-week-old GFP+CD45.1C57BL/6 transgenic mice used as bone marrow 
donor to the wild type C57BL/6 mice. The donor mice were euthanized using 20% CO2 and 
after cervical dislocation, carefully skin is peeled from hind limbs and femurs, tibia and humeri 
were removed, all the muscles were scraped away with sharp scalpel, the bones were collected 
in HBSS with 2.5% Fetal calf serum in ice. Both edges of the bone were excised and bone 
marrow isolated by flushing HBSS with 25-gauge needle, the bone marrow suspension filtered 
with 70mm filter (BD-Falcon) and spun at 250g for 5 minutes. The pellet washed in ice cold 
HBSS with 2.5% FCS, red blood lysis/ACK buffer were used to remove RBC and fraction of 
the cell suspension subjected to GFP fluorescence estimation by flowcytometry. Bone marrow 
transplantation performed in 8 weeks old C57BL/6 mice (receivers) were lethally irradiated 
with 4.8Gy with doses in 3 hr. interval each. Bone marrow kept in ice briefly warmed in water 
bath and injected into tail vein. The receivers kept under warm light and tails were soaked in 
warm water at 37°C before transplant. 125ul (8x107 nucleated cells per ml) of un-fractioned 
bone marrow suspension injected within 3-4 hr. of irradiation. Animal health were monitored 
everyday till the end of the experiment. 
2.4 EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) 
In Paper I: After 4-5 weeks of bone marrow transplantation receivers were checked for its 
bone marrow reconstitution. Animals were sedated under isoflurane anesthesia 2-3 drops of 
blood collected from the tail vein into an Eppendorf tube containing 1xPBS in ice. Animals 
were moved back into the cage and checked for 10 minuets, if there any bleeding from the tail. 
The Eppendorf tubes vortexed 5 seconds and analyzed for GFP expression using 
flowcytometry method. Wild type animal blood served as negative control and donor GFP+ 
blood as positive controls in flow cytometry gating. EAE was induced in receiver (female 
C57BL/6 mice) animals that were 14 weeks old as described109,194. Briefly, the inoculum 
prepared by mixing myelin oligodendrocyte glycoprotein (MOG) P35-55 was dissolved in 1x 
Phosphate buffered saline (PBS) and mixed with Freund’s adjuvant (contains 2mg/ml heat 
killed Mycobacterium tuberculosis in miner oil) and injected laterally into mice. Bordetella 
pertussis (75ng) toxin dissolved in PBS, and injected on the day of immunization with MOG 
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and 48h later to all the mice intravenously. Mice were checked for their health and clinical 
symptoms of EAE scored on 0-5 scale109.  
In Paper II: Similar to in paper I, immunization was performed in 7-8 weeks old female Dark 
Agouti (DA) rats. Inoculum prepared by mixing 20ug recombinant MOG prepared in house 
with Incomplete Freud’s adjuvant (IFA) in 1xPBS. At about 200ul of inoculum injected at the 
tail base. Animals were checked for clinical signs of EAE and documented based on EAE 0-5 
scale every day. 
2.5 TRANSPLANTATION OF NEURAL STEM CELLS 
Paper III: Prior to the transplantation, all the animals received 10mg/kg body weight of 
cyclosporine s.c once daily (Sandimmunâ, Novartis) for 3 days before and 3 days after 
transplantation. NSC were collected from the culture and centrifuged at 300xg and collected 
the pellet, washed in PBS and place in ice. At 8-10 days after contusion sutures were opened 
under anesthesia, the spinal cord exposed after removal of adipose tissue. The spinal column is 
stabilized using the stereotaxic frame and small incision made on the dura to insert 
transplantation needle. A glass capillary pulled using pipette puller (outer diameter 120 µm, 
inner diameter 90 µm) is attached to the Hamilton syringe using dental gum. The Hamilton 
syringe system fixed to a holder on the stereotaxis frame and glass capillary carefully inserted 
into the epicenter 1.5 mm deep into the spinal cord and placed for 5 minutes and slowly injected 
NSC into the epicenter. After transplantation of the cells the capillary placed for 5minutes to 
alleviate the pressure is to avoid NSC oozing out from the needle and removed slowly with 
intermediate pauses. The animals received at around 500,000-600,000 cells (single cells and 
small spheres @ 40µm diameter) or 50000cells/µl of 6µl volume in two injection sites. The 
control group received 6µl of PBS instead of NSC. The animal group in diphtheria experiment 
received 100mg/kg diphtheria toxin for 3 days starting immediate after transplantation with 
24h resting period between. 
2.6 HARVESTING SPINAL CORDS 
Paper I: Mice after EAE were sacrificed at determined times after bone marrow 
transplantation, mice were anesthetized with ketamine, 120mg/kg and Xylazine, 10 mg/kg i.p. 
animals were perfused transcardially with warm 37°C PBS followed by ice cold +4°C 
paraformaldehyde in PBS for 24hr, the tissue is extracted from the animals and cryoprotected 
in 15% sucrose solution and then in 30% sucrose solution overnight. The spinal cords were 
sectioned at 60µm using sliding micro tome (SM2000R; Leica), olfactory bulb into 30µm, 
sciatic nerve 16µm (Leica CM 3000). 
Paper II and III: Rats were euthanized with 20% CO2 and decapitated for SVZ cell extraction 
and for spinal cord extraction for immunohistochemistry the animals were given a lethal dose 
of pentobarbital i.p and perfused using peristaltic pump with warm 37°C PBS followed by ice 
cold +4°C paraformaldehyde, whereas in experimental animals for RNA extraction and RNA-
Seq experimental animals were perfused only with ice cold 1x PBS. Spinal cords that were 
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subjected to gene expression analysis are placed in Eppendorf tubes and snap frozen in liquid 
nitrogen and stored at -80°C, and for fluorescence activated cell sorting (FACS) were placed 
in 1xPBS for further isolation. 
2.7 CEREBROSPINAL FLUID COLLECTION AND IMMUNOASSAY 
Paper III: Cerebrospinal fluid (CSF) was collected from the animals before transplantation 
and different time points during the experiments. After euthanization cisterna magna was 
punctured with safety winged IV needle connected to the 1ml syringe. The CSF aspirated from 
the cisterna magna into 1.5 ml Eppendorf tube and snap frozen in liquid nitrogen and stored at 
-80°C for further analysis. Cytokine and chemokines were estimated in CSF using Bio-Plex Pro 
Rat Cytokine 24-plex Assay kit (Bio-Rad, 10014905) using 25 µl of CSF from each animal 
and all samples made duplets and assayed as per manufacturer’s instructions. 
2.8 IMMUNOHISTOCHEMISTRY 
Paper I: Spinal cord section were made 60µm thick and kept as free floating in 24 well plate 
in PBS with 0.01% sodium azide. After washing 1xPBS three times added primary antibody 
Table 1 in appropriate blocking solution, free floating sections incubated overnight at 4°C in 
shaker; removed the primary antibody and washed with 1xPBS for three times and added 
appropriate secondary antibody diluted in PBS and kept at 4°C overnight or 1hr room 
temperature, after washing 3 times with PBS added Hoechst or DAPI for nuclear staining. 
Paper II and III: For single cell immunoassay performed after differentiation of NSC and 
permeabilized with 4% paraformaldehyde (PFA) for 15 minutes and washed with 1x PBS. 
Primary antibody added (Table 1) along the 5% normal goat or donkey serum, 0.3% Triton-x 
100 (Kodak), 0.01% sodium azide (sigma, S-2002) and incubated overnight at 4°C in humidor. 
Whereas for neurospheres the NSC were centrifuged at 300g for 5 minutes, the pellet washed 
with 1xPBS and post fixed with 4% PFA and incubated overnight at 4°C in blocking solution. 
Spheres span 300g for 10minutes for every wash. Secondary antibody diluted in 1xPBS and 
added to the cover glasses and spheres in Eppendorf tube incubated at room temperature for 
1hr, after washing with 1xPBS three times DAPI or Hoechst added for nuclear stain and 
mounted with microscopic slides with Mowiol (Sigma, 81381). The tissue sectioned 16 µm 
thick stored at -20°C were thawed in room temperature and marked the outline of the glass 
slide with paraffin pen (PAP pen) and rehydrated in 1xPBS for 15 minutes. Primary antibody 
(Table 1) added along with blocking solution mentioned above and incubated at 4°C over night 
in humidor, the slides washed with PBS three times and secondary antibody added on to the 
slides and incubated at room temperature for 1hr and washed the secondary antibody with PBS. 
The nuclei stained with DAPI or Hoechst and glass slides mounted in Mowiol to protect from 
photobleaching.  	  
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Antibody Dilution Host Manufacture Cat.No 
Anti GFP 1:1000 Rabbit Molecular probes  G1544 
Anti Calbindin 1:1000 Mouse Sigma  C9848 
Anti NeuN 1:500 Mouse Millipore  MAB377 
Anti Choline acetyltransferase 
(ChAT) 
1:100 Goat Millipore  
 
AB144P 
Anti beta-III tubulin 1:1000 Mouse Millipore  MAB1637 
Anti-microtubule-associated 
protein 2 (Map2) 
1:500 Rabbit Millipore AB5622 
Anti GFP 1:1000 Goat Rockland  600-101-215 
GFAP 1:1000 Rabbit Dako G9269 
Gal C 1:100 Mouse Millipore AB142 
BIII tubuline 1:100 Mouse Millipore  MAB5564 
CD11b 1:100 Mouse Millipore CBL1512F 
Sox2 1:100 Rabbit Millipore AB5603 
BrdU 1:100 Mouse Amersham RPN202 
BrdU 1:50 Rat AbD Serotec MCA2060 
CC1  1:250 Goat calbindin OP80 
GFAP 1:500 Mouse Dako Z0334 
IBA1 1:500 Mouse Wako 019-19741 
Olig2 1:250 Rabbit Abcam Ab109186 
Pax6 1:500 Mouse DSHB AB 528427 
Nestin 1:250 Rabbit Chemicon MAB353 
GFP 1:500 Rabbit Millipore AB3080 
GFP 1:1000 Chicken Abcam AB 13970 
Table: List of antibodies used in the papers  
2.9 ISOLATION OF TRANSPLANTED NSC  
Paper III: NSC were isolated from naïve (uninjured but received NSC) and SCI animals for 
total transcriptome analysis RNA-Seq and NSC were sorted using Fluorescent activated cell 
sorting (FACS) based on the eGFP expression of the cells. Spinal cords were dissected from 
the animals that were perfused with ice cold 1xPBS and dissociated into single cells using 
10U/ml papain (Worthington, L5003126). Myelin and other debris were removed using 
gradient centrifugation with 30%percoll in 1xDPBS (Sigma, P1644). The supernatant 
discarded along with white myelin and carefully the pellet was resuspended in 2ml of FACS 
buffer (1% BSA (Sigma, A8412), 2mM EDTA (Gibco ®, 15575-038), 25mM HEPES (Sigma, 
H0887)). The cell suspension filter using pre-wet 100µm filter with FACS buffer, and then 
with 40µm cell strainer. eGFP positive and negative gating for sorting arranged using eGFP 
positive NSC and eGFP negative wild type NSC from cell culture in BD Influxä cell sorter. 
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At around 20,000 to 25,000 cells per animal were collected independently into separate tubes, 
the cells were centrifuged at 300g for 5 minutes and re-suspended in 1ml Trizol reagent 
(Thermo Fisher, 15596026), vortexed and stored at -80°C for 24hr. cells from Naïve, SCI and 
in-vitro cells were collected at 3week’s and 4 weeks’ time point.  
2.10 RNA ISOLATION AND CLEAN-UP 
Paper III: Total RNA was isolated from spinal cord tissue and also FACS cells. RNease mini 
kit (Qiagen, 74104) used for total RNA extraction from whole spinal cord as per manufacture 
instructions. Briefly, at about 15mg of spinal cord tissue weighed from each animal and stored 
in separate Eppendorf tube, the tissue was lysed mechanically with tissue lyser (Qiagen) in 
lysis buffer (Qiagen). Genomic DNA contamination eliminated using DNase (DNase I Qiagen, 
79254) and RNA from isolated NSC extracted using Trizol reagent (Thermo Fisher, 
15596026). Isopropanol precipitation was performed overnight using 75µg glycogen 
(Invitrogen, AM9516). For RNA-Seq RNA cleanup performed using RNeasy micro kit 
(Qiagen, 74004) according to manufacture protocol. All the sample were depleted of genomic 
DNA after clean-up process, the quality and quantity of RNA measured using NanoDrop 
(Thermo Fisher) and RNA stored at -80°C until further analysis. 
2.11 RT-PCR 
Paper II and III: the forward and reverse primer were designed using primer3 software and 
blasted sequences were verified. A total of 100 ng of RNA used to perform reverse transcription 
using iscriptä cDNA Synthesis Kit (Bio-Rad, 1708891). RT-qPCR was performed in 10µl 
reaction with iQTM SYBR® Green Supermix (Bio-Rad, 170-8887), 5µM forward and reverse 
primers (Paper II and III) using purified cDNA as template. A CFX384 TouchTM Real-Time 
PCR-detection System (Bio-Rad, 1855485) used for amplification (protocol used 95°C for 3 
min, 95°C for 10s, 60°C for 30 s, and 72°C for 30s repeated 39 times). Two technical replicates 
were used for each biological replicate, plate setup, normalization of expression was performed 
in Bio-Rad CFX manager using DDCt method, whereas in paper II the iQ v2.0 software (Bio-
Rad) used for analysis.  
2.12 SEQUENCING RNA FROM ISOLATED NSC 
Paper III: Sequencing libraries for RNA from isolated NSC after 3 and 4 week 
transplantation were prepared using SMARTer Stranded Total RNA-Seq Kit- Pico Input 
Mammalian (Clontech) from total RNA. Libraries werr sequened 2x125bp on 2 lanes using 
HiSeq2500 (Illumina Inc) on high-output mode. For each replicate a minimum of 
(188e6*2)/28=13.4e6 read-pairs were used. TrimGalore (Babraham Bioinformatics) was 
used for removal of low- quality regions and adapter sequences. Read-pairs were aligned to 
a rat reference genome (Rnor_6.0) using STAR. Differential gene expression analysis was 
conducted in R (version 3.4.4) using packages LIMMA and edgeR 
(https://bioconductor.org/). Functional analysis conducted using WEB-based gene SeT 
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AnaLysis Toolkit (http://www.webgestalt.org/option.php/) and Uniport 
(https://www.uniport.org). 
2.13 TRANSFECTION OF NSC 
Paper III: NSC were selectively ablated using Diphtheria toxin receptor (DTR) expression 
system. The DTR system is non-integrating, self-replicating enhanced episomal vector system 
(EEV) which was modified (EEV600A-1, System Biosciences) used to transfect the NSC. The 
entire DTR-2a-mCherry flanked by restriction enzyme sequences BamHI and Xhol was 
synthetized at Eurofins Genomics195,196. The sequence was directionally cloned into the multiple 
cloning site of the EEV downstream of the existing CAG promoter and transfection efficiency 
determined by visualizing the mCherry fluorescence under microscope. EEV plasmid was 
purified using the EndoFree Plasmid Maxi Kit (Qiagen, 12362), and NSC were transfected 
using Neonâ transfection system. At around 200,000 cells were re-suspended in buffer T and 
mixed with 0.5-3 µg DNA and electroporation set at 990V, for 40 ms, 1 pulse. The cells were 
immediately transferred to culture dishes containing warm NSC medium that was used for 
transplantation after 48hr of culture. The transfection efficiency was checked under microscope 
prior to transplantation. 
2.14 SPINAL CORD INJURY 
We established contusion model of injury in our lab, where we used commercially available 
IH impactor (Infinite Horizon, IH-0400). We observed that stabilization of spinal cord was a 
problem in our hands and that might have effect on the outcome. We modified the instruments 
to stabilize the spinal cord without affecting the functionality of the instrument. For this, we 
replaced the spinal cord holders including animal platform with a stereotactic frame that 
contains bilateral fixators (Kopf ® 900&900-C). We evaluated the impactor performance by 
confirmed reproducibility.  
Paper III: Female Lewis rats that were non-carriers of eGFP were transported to animal 
surgery room one day prior to the spinal cord injury so that they adopt to the environment. All 
the animals were anaesthetized with 4% isoflurane (Baxter) initial induction and later to 2-3% 
during the operation procedure and administered 0.05mg/kg buprenofin s.c (Temgesic®, 
Indivior 0.3 mg/ml), 5 mg/kg karprofen s.c (Rimadyl® vet. Orion Pharma Animal Health, 50 
mg/ml) animals were weighed. The fur is shaved on the back of the animal with hair trimmer 
( Aesculap®, ISIS 273278), applied disinfectant iodine solution on the skin and animal placed 
on the heating pad (37° C) and applied ointment(Oculentum simplex, APL) on eyes to stop 
drying. A longitudinal incision made on the dorsal side using scalpel above the thoracic spine, 
the muscles carefully separated without any bruise and spinal column is stabilized using the 
bilateral fixators in a stereotaxic frame (Kopf ® 900&900-C). Laminectomy was performed 
using the pincer and a surgical drill (ANSPACH ®, EMAX ® 2) at Th11, dura and spinal cord 
were exposed. The rat gently moved under the impactor tip (Infinite Horizon, IH-0400) and a 
force of 200kdyn contusion SCI was delivered. The impact was observed under surgical 
microscope and contusion was considered successful if animal showed an extension of the 
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hindlimbs followed by a flaccid palsy and the software indicates displacement of 1.5 ± 200mm 
of displacement and also paraplegia for two days. In the sham laminectomy group animals 
underwent surgery except for the contusion. The injury was covered with a piece of 
subcutaneous adipose tissue from the same animal in order to fill the cavity generated due to 
laminectomy. All the animals received basic care that include administration of Buprenorfin 
and Karprofen daily for three days and urinary bladder emptied twice a day until the animals 
recovered their bladder function. 
2.15 KINEMATICS INSTRUMENT AND ANALYSIS 
Paper III: To evaluate hind limb locomotor improvement by unbiased scoring system we used 
kinematic along with traditional scoring system described in197. We custom built the instrument 
in our lab using 100cm Plexiglas as runway platform for animals, mirrors that provide side and 
bottom view of the animal and videos recorded using a camera (Canon EOS 6D), camera is 
connected to the computer to record video (EOS utility software). In order to record animal 
walking patterns in every frame in detail we set camera at 60 fps an 1/800 of shutter speed. 
LED light is passed through the glass platform so that animal foot prints that were generated 
by distracting the light (Figure 5).  
 
Figure 5. Kinematic instrument setup: a. custom built instrument using Plexiglas, mirrors and 
camera. b-c animal walking platform and bottom view of the animal foot prints, d. showing tracking of 
hindlimb movement from top to bottom: in healthy, spinal cord injured animals that received NSC and 
control animals with spinal cord injury no stem cells but saline. 
 
To increase intensity and better visualization of footstep we prewet the glass surface. The 
videos were analyzed using Click Joint, AEA solutions (We tested and improved software so 
that it can be used in our setup). Rats fur is shaved and marked joint, Hind limb joints iliac 
crest, greater trochanter (hip), lateral malleolus (ankle), metatarsophalangeal joint of fifth toe, 
tip of the toe for tracking in the software198. For analysis we excluded first and last 10 cm of 
runway from the video only 80cm walking distance were analyzed. For paraplegic animals 
random frames were selected for analysis and we measured iliac crest height, stride width and 
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length, footsteps, velocity, protraction and retraction distance in walking. During grid walking 
analysis we trained the animals on ladder with constant width and while in experiment we 
removed random rugs from the ladder. 
2.16 TISSUE CLEARING  
To better understand how native and transplanted cells interact with tissue they reside it is 
important to visualize them in thick tissue. Traditional process like tissue section and 
immunohistochemistry are very good tools for this purpose. However, sectioning of tissue 
makes researcher to oversight crucial information where three-dimension visualization is 
needed. A major problem is to make thick tissue transparent without affecting its integrity and 
structure.  
 
Figure 6. Optical clearing of rat spinal cord from left to right: perfused with intact myelin, 
semitransparent using CLARITY, See DB for 2 days and transparent spinal cord after CLARITY and 
see DB protocol. 
Recently, number of methods are developed for this purpose. We tested and adopted different 
methods like CLARITY199, see DB200 and CUBIC methods in our lab (Figure 6). Paper III: 
For thick tissue whole spinal cord is cleared for light sheet microscope imaging optical clearing 
methods CUBIC-1 were used as described in Etsuo a susaki et.al201,202. Propidium iodide (PI) 
was used for nuclear staining for light sheet microscopy imaging due to its high penetration 
into the thick tissue. 
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3 AIMS 
 
The general aim of the thesis is to investigate alternative regenerative mechanisms governed 
by stem cells from bone marrow, spinal cord and brain in disease models like MS and SCI. 
 
Specific aims: 
1. To investigate whether cell fusion phenomenon could occur in the inflamed spinal 
cord? 
2. To determine effects of distant inflammation on endogenous NSC in uninflamed parts 
of the spinal cord. 
 
3. To investigate if/how the transplantation of adult neural stem cells may improve 
hindlimb function in rat model of spinal cord injury. 
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4 RESULTS AND DISCUSSION 
 
4.1 PAPER I: CELL FUSION BETWEEN SPINAL MOTOR NEURONS AND 
BMDC  
Cell fusion process is well documented in CNS especially in cerebellum where binucleated 
Purkinje neurons have been identified106,109,203-207. We have previously demonstrated that bone 
marrow derived cells (BMDC’s) can fuse with Purkinje cells in cerebellum and during 
inflammation and fusion events increased by 100 folds109. When other groups were analyzed 
the cerebellum from the multiple sclerosis (MS) patients they not only detected binucleated 
Purkinje cells203,204 but also that the number of heterokaryons were increased significantly 
during EAE disease203. Even though, the exact mechanism is yet to be identified, the question 
remains unanswered, is the fusion process limited to cerebellum or did it also exist in other 
parts of CNS such as spinal cord? 
Since the BMDC’s fuses with wide varieties of the tissues like cardiomyocytes, hepatocytes, 
skeletal muscles, pancreas, lung epithelial tissues, kidney, skin, Purkinje neurons and other 
tissues during normal as well as tissue repair process108,208-215. We hypothesized that 1. The 
cell fusion event between BMDC and CNS might be not restricted to cerebellum and 
might be extended beyond cerebellum, 2. Did the rate of fusion events vary with in the 
cerebellum? specifically in MS where inflammation is key player in disease progression. We 
used similar animal models that were used previously like EAE and bone marrow 
transplantation106,109 where spinal cord was mostly inflamed. We performed bone marrow 
transplantation between GFP+CD45.1C57BL/6 transgenic mice as donor and C57BL/6 mice 
wild type mice as receiver and induced EAE after bone marrow had reconstituted fully. All the 
BMDC’s that had entered into CNS will be expressing GFP (GFP+) and the immune cell 
infiltration can be easily assessed by detection of GPF expression since, cell fusion between 
BMDC’s and Purkinje cells results expression of GFP protein in Purkinje cells109. The number 
of GFP+ heterokaryons were quantified in the entire neuroaxis olfactory bulb, retina, cerebrum, 
cerebellum, brain stem and spinal cord. To confirm if BMDC’s generated heterokaryons in 
cerebellum, we quantified the number of heterokaryons between immunized and non -
immunized mice. The number of heterokaryons were significantly more in the area where there 
was immune cell infiltration due to ongoing EAE inflammation. Purkinje neurons were 
quantified in vermis and lateral hemispheres of the cerebellum and we found more 
heterokaryons in the vermis as compared to lateral hemispheres. The difference in number of 
heterokaryons might be due to more infiltration of cells in vermis than lateral hemispheres and 
also, we believe this might be due to differences in the development and degeneration process 
within cerebellum. We also identified heterokaryon formation in the spinal cord motor neurons 
and some of them were bi-nucleated. The motor neuron whose cell body is located in ventral 
spinal cord and extends its axon into sciatic nerve and connect to muscle fibers in the hind 
limbs. Based on anatomical location (ventral horn of the spinal cord) and expression of GFP in 
nerve fiber/axon in sciatic nerve and expression of NeuN and ChAT in these cells were 
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confirmed to be motor neurons (Figure 7). We recognized some interneurons in spinal cord 
also capable of fusing with BMDC’s and forming heterokaryons. We also detected very few 
MAP2+ neurons in olfactory bulb and in pons area of brain stem. In fact, we didn’t detect any 
heterokaryons in cerebrum and hippocampus, this might be due to poor infiltration of 
leucocytes/lack of inflammation in these areas in this animal model. The absence of binucleated 
cells in some of the neurons might be due to 1. Technical difficulties such as, missing of 
complete cell body due to sectioning, 2. Transdifferentiation of BMDC’s into neurons, which 
is least likely scenario due to complexity of motor neurons but can’t be ruled out completely, 
3. Recent reports on microRNA and mRNA transfer through extracellular vesicles called 
exosomes to neurons216. 4. Nanotubes transfer of genetic material; outside the CNS, 
mitochondrial transfer through nanotubes from healthy to damaged tissue has been reported, 
we might expect similar mechanisms as well217.  
 
 
 
Figure 7: Cell fusion between BMDC’s and Motor neuron in spinal cord: (A) Spinal cord showing 
infiltration of GFP+ leucocytes (green) and ventral horn motor neuron shown (in side box). (B-D) Motor 
neuron (arrow head) expressing NeuN (red) and showing colocalization with GFP (green). 
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4.2 PAPER II: LONG DISTANCE EFFECTS OF INFLAMMATION ON NSC 
In paper II we addressed how inflammation affects neural stem cells niche in spinal cord where 
there is negligible number of infiltrated cells and the spinal cord appear normal during EAE. 
Lesions in this model of MS where there is active inflammation is ongoing is well documented. 
Non-lesion areas in CNS are great importance in understanding MS disease and progression. 
It been reported that when CNS from MS patients analyzed outside lesion area which appear 
to be normal (normal-appearing white matter (NAWM)) may contains pre-active lesions218-221. 
Altered water diffusion properties, gene expression profile and hypoxia222. Clusters of 
microglia have been reported in NAWM compared to healthy tissue which indicates that an 
endogenous inflammatory reaction might exist in the entire white matter of MS brain219,220,223. 
NAWM is very interesting region that might have clues in the initiation of MS lesions. 
Apparently, the immediate question comes whether the neural stem cells in the NAWM 
were affected by distant inflammatory dediators? We used here EAE animal model to 
address this question and estimated the nitrite concentration in cell culture. The NSC 
proliferation and differentiation potential was compared between NSC from lesion area and 
NAWM area. Previously our group showed the altered gene expression and differentiation in 
NSC that were isolated from different regions of spinal cord during EAE224. Nitric Oxide (NO) 
is produced at elevated levels during inflammation225. An induced form of nitric oxide synthase 
(iNOS) enzyme secreted by astrocytes and macrophages is activated during inflammation226. 
Nitrite or nitrate which are the oxidized products of NO can be measured in cerebrospinal fluid 
of patients with MS225,227-229 and other inflammatory diseases such as rheumatoid arthritis230. 
Since the nitrite levels are directly proportional to the degree of inflammation in MS and EAE 
we used this method to distinguish between inflamed spinal cord (ISC) and NAWM in NSC 
culture system. NSC from spinal cords were isolated, where the spinal cords were divided into 
cervical, thoracic and caudal parts in healthy as well as EAE rats224 and nitrite levels in NSC 
culture supernatant were measured using Griess assay231. 
NSC proliferation was estimated using BrdU and it appear that thoracic NASC derived NSC 
have significantly higher rate of proliferation compared to NSC from healthy animals 
indicating that the NSC at NAWM are also affected due to inflammation. In response to injury 
NSC present at ependymal region proliferates, migrates and differentiates during regeneration 
event in spinal cord10,13,232-234 in EAE235, root hypoglossal root avulsion injury11 and in stroke236. 
Gene expression analysis performed at 0hours, 24hours and 5days after differentiation using 
RT-qPCR method, we found that Notch-1 gene is upregulated in both undifferentiated and 
differentiated culture at zero hours and later it was down regulated after 5 days of 
differentiation. Surprisingly the Hes-1 (a downstream mediator of Notch-1 signaling) 
expression was not matched with Notch-1 expression (0hours) indicating that Notch signaling 
acting through Hes independent pathway. The expression of Mash-1 increased at 0hours in 
NASC cultures then, it was downregulated at 24hours of differentiation, neurogenin 2 another 
regulator of neurogenesis, is also upregulated 24hours after differentiation in NASC cultures. 
In agreement with the pro-neural gene expression, we observed b-III-tubulin expression 
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24hours after differentiation in NASC cultures. Furthermore, immunohistochemistry 
quantification data (using b-III-tubulin, GFAP and Gal-C labelling) revealed a significant 
increase in neurogenesis in differentiated NSC culture from NASC than control, whereas 
oligodendrocytes percentage was decreased in NASC-derived cultures. This data contradicts 
with the previous results, where in-vivo setting NSC from spinal cord during EAE were 
differentiated in neurons235 and NSC cultures from spinal cord and SVZ were differentiated 
predominantly into oligodendrocytes237-240.Transplantation animal models affirm that spinal 
cord is more gliogenic than brain, however, inflammation such as EAE could reverse this in 
NSC.  
Taken all together, this study demonstrates that 1. NSC are affected in EAE even though they 
were localized in non-lesion NASC area, 2. Inflammation such as in MS and EAE animal 
model can alter the NSC differentiation potential towards neurogenic fate and reduces 
oligodendrocyte differentiation. It’s exciting and vital to know how inflammatory mediators 
produced at lesions can affect over long distance, one obvious explanation is through 
cytokines/chemokines that were mediated by CSF. Further studies are needed to conclude how 
NSC alter their fate while they were exposed to inflammation that might give insight into how 
NASC might develop lesions as disease progress.  
4.3 PAPER III: SPINAL CORD INJURY AND ADULT NEURAL STEM CELLS 
TRANSPLANTATIONS 
Previously, our research group demonstrated that, adult neural stem cells from ependymal 
region proliferates, differentiates and migrates towards the injury in hypoglossal nerve 
avulsion11. As discussed in “Adult stem cells” section SVZ are the good source of stem cells in 
rodents, our group also shown that upon transplantation of adult neural stem cells from 
subventricular zone (SVZ) differentiates into neurons and able to form synaptic connections 
with the host tissue after hypoglossal injury in rats241.  
An apparent follow-up question comes whether the transplantation, differentiation and 
integration of neural stem cells in injury paradigm leads to functional recovery in these 
animals? How the transplanted neural stem cells interact with injury environment? We 
choose spinal cord injury contusion model over hypoglossal injury and EAE because to 
evaluate functional improvement and the injury is localized than in EAE (model used in paper 
I and Paper II). Here we used inbred LEW-Tg(EGFP)455Rrrcc and sibling neural stem cells 
approach so that the tissue rejection is minimized11,242-245. Neural stem cells were isolated from 
SVZ and propagated 8,13,242,246 in-vitro from Lewis rats carrying eGFP under ubiquitin promoter 
on chromosome 5 and female rats those were non-carriers of eGFP subjected to contusion 
model of spinal cord injury179,180,247-253. After 8-10 days of post injury the neural stem cells were 
transplanted into the epicenter254-257. Several articles published in transplantation of neural stem 
cells and functional recovery of animals147,149,243,245,256,258-266 in which NSCs integrates and 
extends axons across the injured area147,153,267. The major pathways in which the animals 
recovery is due to 1.differentiation into astrocytes, oligodendrocytes and neurons; 2. Changing 
the environment by secreting trophic factors like mesenchymal stem cells268,269 and reducing 
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the secondary damage by interacting with microglia and macrophage270 secreting vascular 
endothelial growth factor and enhancing angiogenesis270,271. However, these results have led to 
confusions in understanding the precise mechanism of action of neural stem cells in spinal cord 
injury models. In this study we investigated global transcriptomal changes within the NSC that 
were subjected to 3 and 4 weeks of transplantation in SCI. The animals that received NSC 
performed better in the classical BBB hind limb locomotor scaling system272 in agreement with 
the previous experiments149,243,245,256,258,262,269,273-275. We observed the NSC had tendency to 
migrate and fill the cyst and differentiate predominantly into oligodendrocytes (CC1), 
astrocytes (GFAP) and few neurons (ß-III tubulin). The effect of NSC transplantations on the 
inflammatory process following SCI was analyzed using the cerebrospinal fluid from the rats 
that were transplanted with NSC and control animals at 3,6 and 12 weeks after SCI. We 
observed lower expression of the pro-inflammatory cytokines/chemokines at week 3 in NSC 
transplanted animals compared to saline control animals which indicates that NSC 
transplantation suppresses the pro-inflammatory response and might be reducing secondary 
damage. 
To evaluate further we isolated NSC after 3 and 4 weeks following SCI and naïve 
transplantation (no SCI) as control animals and determined global transcriptomal changes. We 
found significant separation between NSC that were exposed to SCI, naïve and in-vitro controls 
which indicates NSC that exposed to injury had great impact on the their transcriptomal 
changes. There were many genes that control cell migration, synaptic signaling, 
neurotransmitter releases, axon formation, differentiation, proliferation, myelination and 
regulation of inflammation have been up-regulated in NSC that were exposed to SCI milieu.  
Another interesting aspect of this study is apart from the classical hind limb assessment of 
recovery scoring system, we also performed kinematic gait analysis of hind limbs of all the rats 
following SCI and NSC transplantation (we custom build the apparatus explained in detail in 
the method section). Unbiased analysis of hind limb motor recovery is crucial to assess the 
effect of transplanted NSCs and more over without significant restoration of hind limb function 
transplantation will be futile. When we monitored the recovery using the Basso, Beattie, and 
Bresnahan (BBB) scaling system, the NSC transplanted animals recovered significantly better 
than controls after four weeks of SCI and this continued until experimental termination i.e.,15 
weeks of post SCI. Iliac crest height (ICH) will be significantly lower in SCI animals197. We 
identified that ICH was higher in the SCI animal with NPC than the control rats at 6 weeks of 
post injury. We also performed gait analysis like step cycle, distance between the hindlimbs, 
all these parameters confirmed that the animals that received the NSC after SCI were recovered 
significantly better than the control animals. To determine coordinated stepping, we measured 
stepping patterns using hind limb foot prints at three, six and twelve weeks after SCI. It was 
confirmed that the stepping patterns in NSC transplanted animals were more similar to healthy 
controls. Taken all the evaluation of hindlimb parameters together it was confirmed that the 
animals that received NSC after SCI performed superior in recovery in hind limb locomotor 
function compared to the control animals. 
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We extended the study further to investigate the causal or side effect relationship between 
transplantation of NSC and enhanced recovery of hind limb function. Where we eliminated 
grafted NSCs immediately after transplantation and assessed inflammation profile of 
cytokines/chemokines in cerebrospinal fluid and hindlimb recovery using kinematics. Here we 
used diphtheria toxin receptor (DTR) ablation model where DTR was transfected to NSC using 
non-integrating self-replicating enhanced episomal vector (EEV) with mCherry (that enable us 
to recognize transfected NSC in red color). DTR was expressed on the surface of successfully 
transfected NSC undergo death by apoptosis after diphtheria toxin administration. When cells 
were ablated we observed that these animals had significantly lower ICH, BBB scores 
compared to animals with vital NSC. Moreover, we also observed elevated levels of monocyte 
chemoattractant protein (MCP-1) in NSC ablated animals, but this might be due to ongoing 
apoptotic death of NSC that attracted macrophages276.  
Finally, based on our experiments the overall possible mechanisms of recovery by which NSC 
exerts are 1) NSC differentiate into oligodendrocytes, astrocytes and neurons, where we 
observed that majority of cells differentiated into oligodendrocytes (CC1 positive) in white 
matter. More over gene expression analysis also confirmed the upregulation of myelination 
related genes, which indicates NSC in fact initiates a myelination process possibly contributing 
to improved function and also contributing to scar formation by differentiating into GFAP 
astrocytes. 2) Cytokines/chemokine analysis in CSF confirmed that NSC interacted with the 
injury environment and reduced pro-inflammatory cytokines which might reduce secondary 
damage. 3) Total transcriptome analysis identified range of genes involved in growth factor 
secretion, secretory molecules, and genes related to mitochondria changes. 4) Taken into 
consideration where we transplanted cells in the epicenter and observed NSC in entire lesion 
and transplantation data from immunohistochemistry and LSFM indicates NSC able to migrate 
in the injury even in 7days of transplantation. Since we transplanted the cells into the epicenter 
of the injury that will raise question that migration effect is due to transplantation itself, but as 
we transplanted the cell at 8-10days after injury where the cyst not yet generated due to ongoing 
inflammation we rule out such speculation. We believe the recovery was due to migration and 
transplantation the cells fill the cyst and NSCs’ exerts a multi-dimensional approach during 
SCI that leads to hindlimb motor recovery (Illustrated in Figure 8). 
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Figure 8: Overview of paper III results: Multi-dimensional action of NSC during spinal cord 
injury that leads to hind limb recovery. 	  
 34 
5 CONCLUSIONS 
 
In Paper I. We conclude that cell fusion is not restricted to cerebellum but it also occurs across 
the neuroaxis from olfactory bulb to spinal cord and it is increased in inflamed areas. We further 
conclude that, BMDC fuse with motor neurons in spinal cord and inter neurons during 
inflammation. Moreover, cell-cell fusion phenomenon increases with increased inflammation 
such as EAE. 
 
In Paper II. We conclude that, stem cells that are distant from active inflammation were almost 
equally affected in proliferation and differentiation as cells in areas where inflammation was 
fulminant. NSC isolated from normal appearing white matter showed, altered gene expression 
and differentiation potential in-vitro.  
 
In Paper III. We demonstrated that transplanted NSC in spinal cord injured rats improves their 
hind limb locomotor function. The majority of NSC differentiates into oligodendrocytes, 
astrocytes and few neurons. NSC survive in the spinal cord for 15 weeks and filled the cyst. 
Analysis of CSF showed NSC reduced pro-inflammatory cytokines at 3 weeks after injury and 
gene expression analysis indicated that the expressed genes were altered after 4 weeks of injury. 
Kinematic and BBB scoring system for hind limb function showed that, the animals that 
received NSC recovered significantly better from the injury. Diphtheria toxin induced NSC 
ablation after transplantations confirmed that the animal hind limb recovery was due to actions 
exerted by the grafted NSC. 
 
Finally, it seems as highly differentiated neurons that are difficult to regenerate can be rescued 
using cell fusion while other cells possibly be regenerated by stem cell transplantation. The 
mechanism regulating inflammation and regeneration needs to be investigated further, which 
could be a stepping stone towards therapy in neuroinflammatory diseases or CNS injuries. 
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Figure 9 Illustration showing thesis conclusion: 1. Bone marrow derived cells fuses with 
spinal cord motor neurons, interneurons and forms heterokaryons, increase cell fusion observed 
during EAE inflammation. 2. Endogenous NSC outside the lesion are affected in spinal cord 
during EAE inflammation. 3. Transplanted NSC can enhance functional recovery of the animal 
by differentiation, migration and filling the cavity, reducing inflammation, which further 
reduce the secondary damage and possibly by myelination of axons. 	  
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6 FUTURE PERSPECTIVES 
 
What is the mechanism behind cell fusion and how it used for regeneration safely? 
It is very clear that most of the tissue regenerative process is associated with cell fusion 
phenomenon. Degeneration of Purkinje neurons were observed in many neurological disorders 
such as MS, spinocerebellar ataxia, stoke, murine Niemann-Pick type C1 disease and spinal 
motor neuron degeneration in Amyotrophic lateral sclerosis (ALS). It’s been hypothesized that 
highly complex neurons such as Purkinje neurons and motor neurons in spinal cord, which 
can’t be replaced with transdifferentiating approach might be protected and rescued by 
receiving genetic material from blood through cell fusion. Even though, cell fusion 
phenomenon observed in normal, pathological conditions and during regeneration and tissue 
repair process the exact mechanism not yet fully understood, moreover, there are several 
reports identified fusion process associated with tumors causes concern277-279. There are no 
reports on cell fusion induced malignancies in CNS but the precise mechanism of fusion must 
be identified to demonstrate clinical safety and efficacy. Identifying the precise mechanism of 
fusion and controlled enhancement of cell fusion events can be encouraging approach in many 
neurological diseases like Parkinson’s and Amyotrophic lateral sclerosis (ALS). Moreover, it 
is necessary to identify other mechanism such as microRNA transfer by exosomes, 
mitochondrial exchange during fusion, transfer of mitochondria by nanotubes that were 
reported in CNS as well. 
How NSC that are in distant from lesions in MS model affected? 
The complexities of immune system that affect neurological disease makes difficult to interpret 
how regeneration potential of NSC changed in MS. However, it has been speculated that new 
lesions might arise due to inhibitory effect on oligodendrocyte progenitors in disease condition. 
In this study we observed that NSC in the non-affected area also changed their differentiation 
potentials, more over this study might give insight into the consequences of inflammation also 
at a seemingly unaffected spinal cord, this might be the cause of disease progression and 
supports the notion of early and efficient treatments 
How can cytokines move around in the CNS- transferred by the glymphatic pathways? 
Choroid plexus and epithelial cells act as the barriers between blood and CSF. Recently, it has 
been identified that, the new drainage system to eliminate soluble proteins and metabolites 
from CNS is called glymphatic system280. During MS and EAE inflammation, 
cytokines/chemikines are released into CSF and also NSC are identified to be in contact with 
CSF with their apical projection (Figure 4 explained in adult stem cells section). There is a 
constant transportation of extracellular fluid and CSF allowing for transportation of cytokines 
and reactive oxygen species far away from their site of generation. This may occur in the CSF 
but also via the glymphatic system. 
  37 
How transplantation of NSC leads to recovery of hindlimb function and what are the 
things needed to consider translating to clinic? 
Initial transplantation studies with NSC from embryonic origin is a limited source, technical 
issues and problems with teratoma formation and may limit this type of transplantation-based 
cell therapy. Applying good manufacturing protocols (GMP), basic understanding of NSC 
made to established protocols to purify and characterize NSC, this avoiding teratoma forming 
cells. However, tissue rejection is major problem in transplantation therapy, even though, 
induced pluripotent stem cells (iPS) seems promising and are considered as renewable 
autologous cells in regenerative medicine, several reports have indicated immune rejection in 
mice experiments281,282. Our group previously demonstrated that, transplantation of NSC 
between immune compatible inbred rats resulted in integration into host tissue241, which 
indicates less or no immunogenicity of grafted NSC. Here, we used similar approach, that is 
transplantation between immune compatible sibling rats with intact immune system, so that, 
the immunogenicity of grafted cells can be ignored or given least priority, while in evaluating 
the beneficial effects of NSC. However, the major problem in adult NSC transplantation is the 
source and limited availability of NSC. This needs to be solved either by using reprogramming 
technology or by other techniques. Even though, we and many groups observed improvement 
in hindlimb function in animal models SCI after NSC transplantation, it is necessary to 
investigate carefully the efficacy of transplantation before going to clinical trials because of 
substantial differences exists between humans and animals. The majority of transplantation 
studies have reported modest to significant recovery in animal models of SCI with different 
types of stem cells. This often confuse in determining which cell type is best for transplantation. 
Finally, the fundamental mechanisms of stem cell therapy are still not well understood and 
there is a need to study the basic mechanism of injury and effects of disease on the regenerative 
properties of the CNS. 	  
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